Furthermore, our comparative Western blot analysis revealed lower expression levels of mTOR, p-mTOR, Akt, and RAB27A in GBM-N019 treated ExospU251 and ExospU87MG cells compared to their control counterparts (Figure 7D). This evidence concerns the gene AKT1 and glioblastoma.